5,080
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer

, , , , , , , , , , , ORCID Icon & show all
Article: 2202104 | Received 18 Jan 2023, Accepted 10 Apr 2023, Published online: 17 Apr 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.